Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
dimanche, octobre 18
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Rapid Micro Biosystems Inc
RPID
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.7644
-0.0807
-9.55%
Dern. MÀJ: Oct 16, 5:37 PM
$0.7775
-0.0676
-8%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Privacy Manager
Rapid Micro Biosystems Financials
Rapid Micro Biosystems (RPID) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.133M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.133 million estimate.
Benzinga Newsdesk
PRO
Rapid Micro Biosystems Q2 EPS $(0.27) Misses $(0.24) Estimate, Sales $8.054M Beat $7.875M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.24) by 12.5 percent. This is unchanged from the same period last year. The company
Benzinga Newsdesk
PRO
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.225M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.225 million estimate.
Benzinga Newsdesk
PRO
Rapid Micro Biosystems Q1 EPS $(0.31) Misses $(0.23) Estimate, Sales $8.002M Beat $7.600M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.23) by 34.78 percent. This is a 19.23 percent decrease over losses of $(0.26) per
Benzinga Newsdesk
Earnings Scheduled For May 13, 2026
Benzinga Insights
Earnings Scheduled For March 12, 2026
Benzinga Insights
